AbCellera Biologics (ABCL) news
Recent news
AbCellera prices offering of 17.4M shares at $9.75 each
AInvest Wire · Aug 13, 2026Abcellera Biologics shares down 5.3% after launching $200 mln stock offering
AInvest Wire · Aug 12, 2026Shares of Abcellera Biologics down 7.9% premarket after launching $200 mln stock offering
Shares of AbCellera Biologics Inc. (NASDAQ:ABCL) fell 7.9% in premarket trading on August 12, 2026, following the company’s announcement of a $200 million underwritten public offering of common stock and pre-funded warrants. The offering, led by Jefferies, J.P. Morgan, Cantor Fitzgerald, UBS…
AInvest Wire · Aug 12, 2026AbCellera is said to expect to price share sale Wednesday
AbCellera Biologics Inc. announced the pricing of its initial public offering (IPO) on December 9, 2020, with 24,150,000 common shares offered at $20.00 per share, generating expected gross proceeds of $483.0 million before underwriting discounts and expenses. The shares began trading on the Nasdaq…
AInvest Wire · Aug 11, 2026AbCellera Biologics - proceeds to fund pipeline research, clinical advancement, and working capital
AInvest Wire · Aug 11, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.